Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cellsYulong Gao, Mark J. Smyth, Arabella Young et al.|Nature Immunology|2017Cited by 639
Control of Metastases via Myeloid CD39 and NK Cell Effector FunctionJuming Yan, Mark J. Smyth, Xian-Yang Li et al.|Cancer Immunology Research|2020Cited by 81